Medication info
Zaratan 50 mg (Losartan Potassium)

Zaratan 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200501954 · Notified 2005.03.31 · Insurance code 649402200

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after initiation of treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low dose of a diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased intravascular effective blood volume For patients who may have decreased intravascular effective blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
1. Hypertension 2) Pediatric and adolescent patients aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) This drug is not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension and particularly helps in the prevention and treatment of nephropathy in patients with hypertension and type 2 diabetes. It effectively controls blood pressure, protecting the health of the heart and kidneys, and reducing the occurrence of complications. This drug stabilizes blood pressure management, improving overall health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after initiation of treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low dose of a diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased intravascular effective blood volume For patients who may have decreased intravascular effective blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

1. Hypertension 2) Pediatric and adolescent patients aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) This drug is not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or have the potential to become pregnant. Patients who are allergic to this drug or have severe liver impairment or hereditary angioedema should not take it. Additionally, patients with severe renal impairment or certain heart conditions, and those who have reduced intravascular blood volume should use this medication with caution. Elderly patients or those with high serum potassium levels, or mild to moderate liver impairment should take this drug carefully. Dizziness or hypotension may occur during treatment, so caution is recommended when driving or operating machinery. Because it has blood pressure-lowering effects, if symptoms of hypotension or loss of consciousness occur, consult a doctor immediately. Regular blood tests to monitor kidney function and electrolyte levels are important while taking this medication. Taking potassium supplements or potassium-containing salt substitutes can dangerously increase blood potassium levels, so it should not be taken without consulting a doctor. Moreover, grapefruit juice may reduce the drug’s effectiveness and should be avoided. This medication is not recommended for breastfeeding women; if it must be taken, breastfeeding should be discontinued. In cases of overdose, symptoms such as hypotension and bradycardia may occur, and immediate medical attention should be sought.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory tract infection
Show 123 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disturbance
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • sinus bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dizziness
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitive reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extra systole
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.